Crispr Therapeutics AG PS Ratio 2016–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Current and historical P/S ratio for Crispr Therapeutics AG (CRSP): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 1113.34.

From: 03/31/2017To: 03/31/2026

Stock Price

TTM Revenue

PS Ratio

Crispr Therapeutics AG PS Ratio — FAQ

Crispr Therapeutics AG (CRSP) ps ratio over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CRSP's ps ratio history?

The chart and table above show Crispr Therapeutics AG's ps ratio by year and by quarter, including the growth rate.